Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
Category : Search result: MSME pharma
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
Sitharaman Unveils Banking Reforms & AI Regulation
Finance Minister Nirmala Sitharaman announces transformative banking reforms, AI regulation framework, and GST simplification to fuel India's economic growth at SBI Conclave.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
PNB MetLife Launches 360 Biz Digital Platform for MSMEs
PNB MetLife unveils groundbreaking 360 Biz digital platform, transforming insurance accessibility for India's MSME sector with comprehensive digital solutions.
Jharkhand MSME Bill 2025: 26 Compliance Burdens Axed
Jharkhand Governor CP Radhakrishnan approves groundbreaking MSME Special Exemption Bill 2025, eliminating 26 compliance burdens to accelerate industrial growth and ease of doing business in the state.
Indian Bank MD Backs Jharkhand's Economic Growth
Indian Bank's Managing Director Binod Kumar commits to accelerating Jharkhand's economic development through enhanced banking services, digital transformation, and robust credit support for key sectors.
RegisterKaro Simplifies Pvt Ltd Company Registration
Discover how RegisterKaro is transforming the business landscape by making Private Limited company registration completely paperless, fast, and hassle-free for Indian entrepreneurs.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
J&K LG Pushes MSME & Startup Funding Boost
Lieutenant Governor Manoj Sinha calls for urgent financial support for MSMEs and startups in Jammu & Kashmir to drive economic growth and job creation.
3-Day GST Registration for Small Businesses in India
Indian government introduces revolutionary 3-day GST registration for small and low-risk businesses, streamlining compliance and boosting ease of doing business across the nation.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
UP Decriminalises Trade Offences: Relief for Businesses
In a landmark decision, the Uttar Pradesh government approves proposal to decriminalise minor trade offences, easing business operations and boosting investor confidence across the state.
Indian MSMEs Defy US Tariff Challenges: SIDBI Survey
Despite facing significant US tariff challenges, India's MSME sector demonstrates strong resilience with key performance indices remaining above expansion threshold, according to SIDBI's latest survey findings.
Mukul Agrawal's ₹200 Cr Pharma Stock Bet Revealed
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
B2B Platforms Drive India's $1 Trillion Export Goal
Discover how Indian B2B marketplaces are revolutionizing global trade, connecting MSMEs with international buyers, and driving the nation toward its ambitious export target.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Page 1 of 2